Directors' share dealings

For an overview of the most recent management transactions please consult:

Published notification on management transactions, SIX Swiss Exchange

 

Number of shares held as of 31 December 2011 based on the remuneration report 2011

Board of DirectorsNumber of unrestricted shares held1Number of restricted shares heldRestricted shares grant 2011Restricted shares grant 2010
Rolf Watter253’50013’83211’8322’000
Raymund Breu70’0006’5624’5622’000
Daniela Bosshardt
-Hengartner
-6’5624’5622’000
Stig G. Eriksson4’2506’5624’5622’000
Edgar Fluri16’5006’5624’5622’000
Robert Lilja18’3756’5624’5622’000
Oern Stuge-6’5624’5622’000
Antoine Firmenich1’0003’0003-2’000
Heino von
Prondzynski4
37’80017’25514’2553’000

1 Includes shares acquired in the market
2 Chairman ad interim since 3 July 2011.
3 Number of restricted shares held as of 31 March 2011 (including grants 2010 and 2009).
4 Chairman until 3 July 2011; numbers as of 3 July 2011.

 

Number of performance share units, shares and stock options held as of 31 December 2011 based on the remuneration report 2011

Executive CommitteeNumber of shares held1Number of performance share units held2
Richard Laube110’00032’573
Dirk W. Kirsten2’60045’254
Hans Geiselhöringer3-28’502
Rolf Melker Nilsson-12’512
Petra Rumpf7’90048’544
Jörg von Manger-Koenig-26’001
Nicolas Weidmann-31’205
Ernst Zaengerle4’20023’234
Alexander Ochsner450034’920
Michael G. Thompson4-11’325
Domenico Scala529’28055’812
Hans Schmotzer4-31’343

1 Includes shares acquired in the market.
2 Excluding performance share units which forfeited.
3 Under management service contract.
4 As of 30 November 2011.
5 As of 31 March 2011.

For more information please consult the full Remuneration report. For current shareholding information please view CVs of Board of Directors and Executive Committee.

Investor contacts

Süha Demokan

Süha Demokan

Head of Investor Relations

Nobel Biocare Management AG  
P.O. Box
CH - 8058 Zurich-Airport
Switzerland

+41 43 211 42 30

+41 79 430 81 46

+41 43 211 42 42

Give us your feedback!

Summarize your comments
Email